ROIV financials
Roivant Sciences (ROIV) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ROIV income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $8.26M | $6.97M | -$1.29B | -$299.77M | -0.43 |
| 2024 | $29.05M | $28.14M | -$1.11B | -$171.98M | -0.24 |
| 2023 | $32.71M | $31.11M | -$824.93M | $4.35B | 5.23 |
| 2022 | $31.53M | $28.50M | -$809.01M | -$1.01B | -1.42 |
| 2021 | $55.29M | $46.32M | -$1.21B | -$845.26M | -1.26 |
| 2020 | $23.80M | $21.74M | -$1.07B | -$809.23M | -1.18 |
- ROIV revenue was $8.26M in fiscal 2025, net income -$299.77M.
Updated 2026-11-07 11:54 UTC